Cargando…

Survival benefit from immunocheckpoint inhibitors in stage IV non‐small cell lung cancer patients with brain metastases: A National Cancer Database propensity‐matched analysis

Immunocheckpoint inhibitors (ICIs) have become a standard pharmacological therapy in non‐small cell lung cancer (NSCLC). Because brain metastases (BMs) have historically been listed as exclusion criteria in previous clinical trials involving ICIs in advanced NSCLC, the survival benefit from ICI in N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takamori, Shinkichi, Komiya, Takefumi, Powell, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897968/ https://www.ncbi.nlm.nih.gov/pubmed/33340271 http://dx.doi.org/10.1002/cam4.3675

Ejemplares similares

Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2022)

Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
por: Komiya, Takefumi, et al.
Publicado: (2023)

Prognostic Impact of Single and Multiple Descriptors in Pathologically Staged T3N0M0 NSCLC
por: Komiya, Takefumi, et al.
Publicado: (2020)

Prognostic impact of chronological age on efficacy of immune checkpoint inhibitors in non‐small‐cell lung cancer: Real‐world data from 86 173 patients
por: Takamori, Shinkichi, et al.
Publicado: (2021)

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database
por: Barzi, Afsaneh, et al.
Publicado: (2020)

Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer
por: Hu, Meng, et al.
Publicado: (2022)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

An Overview of Lung and Breast Cancer Using the National Cancer Database
por: Deshotels, Leigh, et al.
Publicado: (2020)

Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score‐matched analysis
por: Geng, Xiuwen, et al.
Publicado: (2016)

Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung
por: Komiya, Takefumi, et al.
Publicado: (2021)

Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

Immunocheckpoint Inhibitor- (Nivolumab-) Associated Hypereosinophilia in Non-Small-Cell Lung Carcinoma
por: Singh, Navdeep, et al.
Publicado: (2020)

Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
por: Pausch, Thomas M., et al.
Publicado: (2021)

Reducing Bias in Cancer Research: Application of Propensity Score Matching
por: Reeve, Bryce B., et al.
Publicado: (2008)

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study
por: Mao, Kai, et al.
Publicado: (2018)

Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis
por: Sun, Jianhui, et al.
Publicado: (2022)

Evaluation of Demographics and Management of Rectal Cancer by Age Group: A Retrospective Propensity Matched Cohort Analysis of the National Cancer Database
por: Bliggenstorfer, Jonathan, et al.
Publicado: (2021)

National cancer database analysis of outcomes in pediatric glioblastoma
por: Liu, Meng, et al.
Publicado: (2018)

Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis
por: Wang, Weiping, et al.
Publicado: (2018)

Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
por: Matteucci, Laura, et al.
Publicado: (2023)

Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
por: Xu, Yuanji, et al.
Publicado: (2017)

Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis
por: Wang, Xiaojuan, et al.
Publicado: (2022)

Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
por: Sussman, Tamara A, et al.
Publicado: (2022)

Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results database
por: Lin, Qiuyan, et al.
Publicado: (2019)

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
por: Kang, Yu‐Mei, et al.
Publicado: (2019)

National Cancer Database report of nonmetastatic esophageal small cell carcinoma
por: Verma, Vivek, et al.
Publicado: (2018)

Surgery in Masaoka stage IV thymic carcinoma: a propensity-matched study based on the SEER database
por: Ye, Cong, et al.
Publicado: (2020)

Dose‐escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score‐matched study
por: Chou, Yung‐Chih, et al.
Publicado: (2017)

The stage‐specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score‐matched analysis of the SEER database
por: Wang, Shijie, et al.
Publicado: (2020)

Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
por: Tae, Bum Sik, et al.
Publicado: (2019)

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
por: Onozawa, Mizuki, et al.
Publicado: (2018)

Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer
por: Komiya, Takefumi, et al.
Publicado: (2020)

Survival benefit of primary and metastatic tumor resection for colon cancer with liver metastases: A population based, propensity score-matched study
por: Qiao, Yunfeng, et al.
Publicado: (2022)

CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade
por: Zheng, Aixian, et al.
Publicado: (2022)

Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis
por: Gao, Yang, et al.
Publicado: (2019)

Comparison of outcomes between symptomatic and asymptomatic patients with colorectal cancer: a propensity score-matched analysis of surgical invasiveness, medical costs and oncological outcomes
por: Inada, Ryo, et al.
Publicado: (2017)

Thoracoscopic segmentectomy versus lobectomy: A propensity score–matched analysis
por: Sesma, Julio, et al.
Publicado: (2022)

Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis
por: Kim, Yi-Jun, et al.
Publicado: (2019)

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score‐matched cohort study
por: Dai, Danian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8o25vujnn4ilgnrm6h6hcer5jh